Análisis de la morbi-mortalidad a largo plazo en trasplante hepático
Texto completo
Figure
Documento similar
The anti-hepatitis B surface antigen (anti-HBs) and anti-hepatitis A virus (anti-HAV) antibody titres observed following a primary vaccination course with Ambirix are in the range
Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome.. Microb
Antiviral activity of Polyanionic Carbosilane Dendrimers as hepatitis C virus entry inhibitors. (Manuscript
We have evaluated the performance of a deep-sequencing-based HCV subtyping assay, developed for the 454/GS-Junior platform, in comparison with those of two commercial assays
Knockdown of clathrin or the clathrin adaptor AP-1 in HCVcc- infected human hepatoma cell cultures impaired viral secretion without altering intracellular HCVcc levels or
En el presente artículo se identificó a través de la metodología utilizada referida al modelo de regresión logística usando la Encuesta Demográfica y de Salud Familiar (ENDES) 2020
Here we aim to describe trends in number of cases and outcomes, namely in-hospital mortality (IHM) and length of hospital stay (LHS), of hospital admissions for major
Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis...